{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T05:42:02Z","timestamp":1771566122030,"version":"3.50.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,13]],"date-time":"2023-11-13T00:00:00Z","timestamp":1699833600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,11,13]],"date-time":"2023-11-13T00:00:00Z","timestamp":1699833600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Institute for Health and Care Research Applied Research Collaboration North East and North Cumbria","award":["NIHR200173"],"award-info":[{"award-number":["NIHR200173"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Thyroid Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Subclinical hypothyroidism is diagnosed when serum thyroid stimulating hormone levels are higher whilst free thyroxine levels remain within their respective reference ranges. These reference ranges are uniformly applied in all adults, despite serum thyroid stimulating hormone levels naturally increasing with age. Research has found that mildly elevated thyroid stimulating hormone levels may be associated with some benefits in ageing patients, including reduced mortality and better cardiorespiratory fitness. Levothyroxine is typically prescribed to patients with hypothyroidism, but no conclusive evidence exists on whether levothyroxine therapy is beneficial or detrimental in older subclinical hypothyroid patients. Despite this, prescriptions for levothyroxine are increasing year-on-year. This study aims to determine if receiving levothyroxine affects the cardiovascular and bone health outcomes of subclinical patients in primary care aged 50 years and over.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This project includes a retrospective cohort analysis and a target trial emulation study using electronic patient records collected between 2006 and 2021 and recorded in The Health Improvement Network database. The primary outcome of this study is to compare the cardiovascular outcomes of subclinical hypothyroid patients aged over 50 years treated with levothyroxine compared to those untreated. Secondary outcomes are bone health and all-cause mortality outcomes. Descriptive and inferential statistics will both be employed to analyse the data. Secondary analysis will explore confounding factors, including age, sex, smoking status, body mass index, co-morbidities, and levothyroxine dosage.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Discussion<\/jats:title>\n                <jats:p>There needs to be a greater understanding of the potential risks of the current treatment for older patients with subclinical hypothyroidism in a primary care setting. We will investigate the clinical importance of this issue and whether older subclinical hypothyroid patients have poorer outcomes when treated. Clarifying this concern may help address the healthcare resource implications of ageing patients being misclassified as having mild hypothyroidism, as these patients are more likely to repeat their blood tests. This could reduce prescription wastage and improve patient outcomes and quality of life in the ageing population.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p>Not applicable.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13044-023-00186-0","type":"journal-article","created":{"date-parts":[[2023,11,13]],"date-time":"2023-11-13T01:02:04Z","timestamp":1699837324000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Assessing the cardiovascular effects of levothyroxine use in an ageing United Kingdom population (ACEL-UK) protocol: a cohort and target trial emulation study"],"prefix":"10.1186","volume":"16","author":[{"given":"Mia","family":"Holley","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salman","family":"Razvi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosie","family":"Dew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian","family":"Maxwell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott","family":"Wilkes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,11,13]]},"reference":[{"issue":"9821","key":"186_CR1","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1016\/S0140-6736(11)60276-6","volume":"379","author":"DS Cooper","year":"2012","unstructured":"Cooper DS, Biondi B. Subclinical thyroid Disease. The Lancet. 2012;379(9821):1142\u201354.","journal-title":"The Lancet"},{"issue":"6","key":"186_CR2","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1111\/cen.12824","volume":"84","author":"O Okosieme","year":"2016","unstructured":"Okosieme O, Gilbert J, Abraham P, Boelaert K, Dayan C, Gurnell M, et al. Management of primary hypothyroidism: statement by the British Thyroid Association Executive Committee. Clin Endocrinol (Oxf). 2016;84(6):799\u2013808.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"186_CR3","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1111\/j.1365-2265.2007.03051.x","volume":"68","author":"GP Leese","year":"2008","unstructured":"Leese GP, Flynn RV, Jung RT, Macdonald TM, Murphy MJ, Morris AD. Increasing prevalence and incidence of thyroid Disease in Tayside, Scotland: the thyroid epidemiology audit and Research Study (TEARS). Clin Endocrinol (Oxf). 2008;68(2):311\u20136.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"186_CR4","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1210\/jcem.87.2.8182","volume":"87","author":"JG Hollowell","year":"2002","unstructured":"Hollowell JG, Staehling NW, Flanders WD, Hannon WH, Gunter EW, Spencer CA, et al. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab. 2002;87(2):489\u201399.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"186_CR5","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1111\/j.1365-2265.1991.tb01739.x","volume":"34","author":"JV Parle","year":"1991","unstructured":"Parle JV, Franklyn JA, Cross KW, Jones SC, Sheppard MC. Prevalence and follow-up of abnormal thyrotrophin (TSH) concentrations in the elderly in the United Kingdom. Clin Endocrinol (Oxf). 1991;34(1):77\u201383.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"186_CR6","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/S2213-8587(21)00285-0","volume":"10","author":"B Biondi","year":"2022","unstructured":"Biondi B, Cappola AR. Subclinical hypothyroidism in older individuals. LANCET DIABETES Endocrinol. 2022;10(2):129\u201341.","journal-title":"LANCET DIABETES Endocrinol"},{"issue":"2","key":"186_CR7","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1001\/jama.2019.9052","volume":"322","author":"B Biondi","year":"2019","unstructured":"Biondi B, Cappola AR, Cooper DS. Subclinical hypothyroidism: a review. JAMA. 2019;322(2):153\u201360.","journal-title":"JAMA"},{"key":"186_CR8","unstructured":"The top 10. causes of death [Internet]. [cited 2021 Nov 26]. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/the-top-10-causes-of-death."},{"key":"186_CR9","unstructured":"British Heart Foundation [Internet]. [cited 2021 Nov 29]. Heart Statistics. Available from: https:\/\/www.bhf.org.uk\/what-we-do\/our-research\/heart-statistics."},{"key":"186_CR10","unstructured":"Population estimates for the UK., England and Wales, Scotland and Northern Ireland - Office for National Statistics [Internet]. [cited 2021 Nov 29]. Available from: https:\/\/www.ons.gov.uk\/peoplepopulationandcommunity\/populationandmigration\/populationestimates\/bulletins\/annualmidyearpopulationestimates\/mid2020."},{"key":"186_CR11","unstructured":"National population projections - Office for National Statistics [Internet]. [cited 2021 Nov 26]. Available from: https:\/\/www.ons.gov.uk\/peoplepopulationandcommunity\/populationandmigration\/populationprojections\/bulletins\/nationalpopulationprojections\/2018based#changes-since-the-2016-based-projections."},{"key":"186_CR12","unstructured":"Robinson J. The Pharmaceutical Journal. [cited 2022 Nov 1]. Prescribing of thyroid hormone increases by more than 60% in a decade. Available from: https:\/\/pharmaceutical-journal.com\/article\/news\/prescribing-of-thyroid-hormone-increases-by-over-60-in-a-decade."},{"issue":"3","key":"186_CR13","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1210\/jc.2012-3191","volume":"98","author":"T Vadiveloo","year":"2013","unstructured":"Vadiveloo T, Donnan PT, Murphy MJ, Leese GP. Age- and gender-specific TSH reference intervals in people with no obvious thyroid Disease in Tayside, Scotland: the thyroid epidemiology, audit, and Research Study (TEARS). J Clin Endocrinol Metab. 2013;98(3):1147\u201353.","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"186_CR14","doi-asserted-by":"publisher","first-page":"3944","DOI":"10.1210\/jc.2012-2481","volume":"97","author":"AC Waring","year":"2012","unstructured":"Waring AC, Arnold AM, Newman AB, B\u00f9zkov\u00e1 P, Hirsch C, Cappola AR. Longitudinal changes in thyroid function in the oldest old and survival: the cardiovascular health study all-stars study. J Clin Endocrinol Metab. 2012;97(11):3944\u201350.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"186_CR15","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1210\/jc.2011-3020","volume":"97","author":"AP Bremner","year":"2012","unstructured":"Bremner AP, Feddema P, Leedman PJ, Brown SJ, Beilby JP, Lim EM, et al. Age-related changes in thyroid function: a longitudinal study of a community-based cohort. J Clin Endocrinol Metab. 2012;97(5):1554\u201362.","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"186_CR16","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1089\/thy.2016.0133","volume":"26","author":"L Chaker","year":"2016","unstructured":"Chaker L, Korevaar TIM, Medici M, Uitterlinden AG, Hofman A, Dehghan A, et al. Thyroid function characteristics and determinants: the Rotterdam Study. Thyroid\u00ae. 2016;26(9):1195\u2013204.","journal-title":"Thyroid\u00ae"},{"issue":"21","key":"186_CR17","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1001\/archinternmed.2009.392","volume":"169","author":"EM Simonsick","year":"2009","unstructured":"Simonsick EM, Newman AB, Ferrucci L, Satterfield S, Harris TB, Rodondi N, et al. Subclinical hypothyroidism and functional mobility in older adults. Arch Intern Med. 2009;169(21):2011\u20137.","journal-title":"Arch Intern Med"},{"issue":"21","key":"186_CR18","doi-asserted-by":"publisher","first-page":"2591","DOI":"10.1001\/jama.292.21.2591","volume":"292","author":"J Gussekloo","year":"2004","unstructured":"Gussekloo J, van Exel E, de Craen AJM, Meinders AE, Fr\u00f6lich M, Westendorp RGJ. Thyroid status, disability and cognitive function, and survival in old age. JAMA. 2004;292(21):2591\u20139.","journal-title":"JAMA"},{"issue":"11","key":"186_CR19","doi-asserted-by":"publisher","first-page":"4385","DOI":"10.1210\/jc.2016-1935","volume":"101","author":"SHS Pearce","year":"2016","unstructured":"Pearce SHS, Razvi S, Yadegarfar ME, Martin-Ruiz C, Kingston A, Collerton J, et al. Serum thyroid function, mortality and disability in Advanced Old Age: the Newcastle 85 + study. J Clin Endocrinol Metab. 2016;101(11):4385\u201394.","journal-title":"J Clin Endocrinol Metab"},{"key":"186_CR20","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.ejim.2017.11.010","volume":"50","author":"A Grossman","year":"2018","unstructured":"Grossman A, Feldhamer I, Meyerovitch J. Treatment with levothyroxin in subclinical hypothyroidism is associated with increased mortality in the elderly. Eur J Intern Med. 2018;50:65\u20138.","journal-title":"Eur J Intern Med"},{"issue":"4","key":"186_CR21","first-page":"e14296","volume":"13","author":"P Panday","year":"2021","unstructured":"Panday P, Arcia Franchini AP, Iskander B, Anwer F, Oliveri F, Kakargias F, et al. Subclinical hypothyroidism in Geriatric Population and its Association with Heart Failure. Cureus. 2021;13(4):e14296.","journal-title":"Cureus"},{"issue":"1","key":"186_CR22","doi-asserted-by":"publisher","first-page":"4","DOI":"10.2174\/1871530311313010003","volume":"13","author":"B Gencer","year":"2013","unstructured":"Gencer B, Collet TH, Virgini V, Auer R, Rodondi N. Subclinical thyroid dysfunction and cardiovascular outcomes among prospective cohort studies. Endocr Metab Immune Disord Drug Targets. 2013;13(1):4\u201312.","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"issue":"4","key":"186_CR23","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1159\/000356507","volume":"2","author":"SHS Pearce","year":"2013","unstructured":"Pearce SHS, Brabant G, Duntas LH, Monzani F, Peeters RP, Razvi S, et al. 2013 ETA Guideline: management of subclinical hypothyroidism. Eur Thyroid J. 2013;2(4):215\u201328.","journal-title":"Eur Thyroid J"},{"issue":"10","key":"186_CR24","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1001\/archinternmed.2012.1159","volume":"172","author":"S Razvi","year":"2012","unstructured":"Razvi S, Weaver JU, Butler TJ, Pearce SHS. Levothyroxine treatment of subclinical hypothyroidism, fatal and nonfatal cardiovascular events, and mortality. Arch Intern Med. 2012;172(10):811\u20137.","journal-title":"Arch Intern Med"},{"issue":"14","key":"186_CR25","doi-asserted-by":"publisher","first-page":"e20","DOI":"10.1056\/NEJMc1709989","volume":"377","author":"A Ogunsakin","year":"2017","unstructured":"Ogunsakin A, Solomon SS, Dagogo-Jack S. Thyroid hormone therapy for older adults with subclinical hypothyroidism. N Engl J Med. 2017;377(14):e20.","journal-title":"N Engl J Med"},{"key":"186_CR26","doi-asserted-by":"crossref","unstructured":"Zijlstra L, Jukema J, Westendorp R, Du Puy R, Poortvliet R, Kearney P et al. Levothyroxine Treatment and Cardiovascular Outcomes in Older People With Subclinical Hypothyroidism: Pooled Individual Results of Two Randomised Controlled Trials. Front Endocrinol [Internet]. 2021;12. Available from: https:\/\/www.cochranelibrary.com\/central\/doi\/10.1002\/central\/CN-02285545\/full.","DOI":"10.3389\/fendo.2021.674841"},{"issue":"1","key":"186_CR27","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1210\/er.2006-0043","volume":"29","author":"B Biondi","year":"2008","unstructured":"Biondi B, Cooper DS. The clinical significance of subclinical thyroid dysfunction. Endocr Rev. 2008;29(1):76\u2013131.","journal-title":"Endocr Rev"},{"key":"186_CR28","doi-asserted-by":"publisher","first-page":"97","DOI":"10.2147\/CIA.S23966","volume":"7","author":"IM Bensenor","year":"2012","unstructured":"Bensenor IM, Olmos RD, Lotufo PA. Hypothyroidism in the elderly: diagnosis and management. Clin Interv Aging. 2012;7:97\u2013111.","journal-title":"Clin Interv Aging"},{"issue":"1","key":"186_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1677\/joe.1.06131","volume":"187","author":"K Boelaert","year":"2005","unstructured":"Boelaert K, Franklyn JA. Thyroid hormone in health and Disease. J Endocrinol. 2005;187(1):1\u201315.","journal-title":"J Endocrinol"},{"issue":"3","key":"186_CR30","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1210\/er.2013-1083","volume":"35","author":"B Biondi","year":"2014","unstructured":"Biondi B, Wartofsky L. Treatment with thyroid hormone. Endocr Rev. 2014;35(3):433\u2013512.","journal-title":"Endocr Rev"},{"issue":"1","key":"186_CR31","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1210\/jc.2009-1625","volume":"95","author":"RW Flynn","year":"2010","unstructured":"Flynn RW, Bonellie SR, Jung RT, MacDonald TM, Morris AD, Leese GP. Serum thyroid-stimulating hormone concentration and morbidity from Cardiovascular Disease and fractures in patients on long-term thyroxine therapy. J Clin Endocrinol Metab. 2010;95(1):186\u201393.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"186_CR32","doi-asserted-by":"publisher","first-page":"36","DOI":"10.3961\/jpmph.2014.47.1.36","volume":"47","author":"YJ Ko","year":"2014","unstructured":"Ko YJ, Kim JY, Lee J, Song HJ, Kim JY, Choi NK, et al. Levothyroxine dose and fracture risk according to the osteoporosis status in elderly women. J Prev Med Public Health Yebang Uihakhoe Chi. 2014;47(1):36\u201346.","journal-title":"J Prev Med Public Health Yebang Uihakhoe Chi"},{"issue":"1","key":"186_CR33","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1001\/jamainternmed.2013.11312","volume":"174","author":"PN Taylor","year":"2014","unstructured":"Taylor PN, Iqbal A, Minassian C, Sayers A, Draman MS, Greenwood R, et al. Falling threshold for treatment of borderline elevated thyrotropin levels-balancing benefits and risks: evidence from a large community-based study. JAMA Intern Med. 2014;174(1):32\u20139.","journal-title":"JAMA Intern Med"},{"issue":"391","key":"186_CR34","first-page":"93","volume":"45","author":"P De Whalley","year":"1995","unstructured":"De Whalley P. Do abnormal thyroid stimulating hormone level values result in treatment changes? A study of patients on thyroxine in one general practice. Br J Gen Pract J R Coll Gen Pract. 1995;45(391):93\u20135.","journal-title":"Br J Gen Pract J R Coll Gen Pract"},{"issue":"4","key":"186_CR35","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1210\/jc.2008-1696","volume":"94","author":"LL Somwaru","year":"2009","unstructured":"Somwaru LL, Arnold AM, Joshi N, Fried LP, Cappola AR. High frequency of and factors associated with thyroid hormone over-replacement and under-replacement in men and women aged 65 and over. J Clin Endocrinol Metab. 2009;94(4):1342\u20135.","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"186_CR36","doi-asserted-by":"publisher","first-page":"4575","DOI":"10.1210\/jc.2007-1499","volume":"92","author":"MI Surks","year":"2007","unstructured":"Surks MI, Hollowell JG. Age-specific distribution of serum thyrotropin and antithyroid antibodies in the US population: implications for the prevalence of subclinical hypothyroidism. J Clin Endocrinol Metab. 2007;92(12):4575\u201382.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"186_CR37","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1111\/j.1365-2265.2008.03390.x","volume":"70","author":"L Boucai","year":"2009","unstructured":"Boucai L, Surks MI. Reference limits of serum TSH and free T4 are significantly influenced by race and age in an urban outpatient medical practice. Clin Endocrinol (Oxf). 2009;70(5):788\u201393.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"12","key":"186_CR38","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1089\/thy.2019.0535","volume":"30","author":"SP Fitzgerald","year":"2020","unstructured":"Fitzgerald SP, Bean NG, Falhammar H, Tuke J. Clinical parameters are more likely to be Associated with thyroid hormone levels than with thyrotropin levels: a systematic review and Meta-analysis. Thyroid off J Am Thyroid Assoc. 2020;30(12):1695\u2013709.","journal-title":"Thyroid off J Am Thyroid Assoc"},{"issue":"2","key":"186_CR39","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s12020-021-02851-6","volume":"74","author":"SP Fitzgerald","year":"2021","unstructured":"Fitzgerald SP, Bean NG, Hennessey JV, Falhammar H. Thyroid testing paradigm switch from thyrotropin to thyroid hormones-future directions and opportunities in clinical medicine and research. Endocrine. 2021;74(2):285\u20139.","journal-title":"Endocrine"},{"issue":"4","key":"186_CR40","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1590\/S0004-27302012000400006","volume":"56","author":"A Bornschein","year":"2012","unstructured":"Bornschein A, Paz-Filho G, Graf H, Carvalho GAD. Treating primary hypothyroidism with weekly doses of levothyroxine: a randomized, single-blind, crossover study. Arq Bras Endocrinol Metabol. 2012;56(4):250\u20138.","journal-title":"Arq Bras Endocrinol Metabol"},{"issue":"4","key":"186_CR41","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1089\/thy.2000.10.335","volume":"10","author":"P Vestergaard","year":"2000","unstructured":"Vestergaard P, Weeke J, Hoeck HC, Nielsen HK, Rungby J, Rejnmark L, et al. Fractures in patients with primary idiopathic hypothyroidism. Thyroid off J Am Thyroid Assoc. 2000;10(4):335\u201340.","journal-title":"Thyroid off J Am Thyroid Assoc"},{"key":"186_CR42","doi-asserted-by":"publisher","first-page":"641560","DOI":"10.3389\/fendo.2021.641560","volume":"12","author":"G Effraimidis","year":"2021","unstructured":"Effraimidis G, Watt T, Feldt-Rasmussen U. Levothyroxine Therapy in Elderly patients with hypothyroidism. Front Endocrinol. 2021;12:641560.","journal-title":"Front Endocrinol"},{"issue":"5","key":"186_CR43","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1111\/jgs.17015","volume":"69","author":"EJ Abbey","year":"2021","unstructured":"Abbey EJ, McGready J, Ferrucci L, Simonsick EM, Mammen JSR. Thyroid hormone supplementation and all-cause Mortality in Community-Dwelling older adults: results from the Baltimore Longitudinal Study of Aging. J Am Geriatr Soc. 2021;69(5):1283\u201390.","journal-title":"J Am Geriatr Soc"},{"key":"186_CR44","doi-asserted-by":"publisher","first-page":"680647","DOI":"10.3389\/fendo.2021.680647","volume":"12","author":"SY Sohn","year":"2021","unstructured":"Sohn SY, Seo GH, Chung JH. Risk of all-cause mortality in levothyroxine-treated hypothyroid patients: a nationwide Korean cohort study. Front Endocrinol. 2021;12:680647.","journal-title":"Front Endocrinol"},{"key":"186_CR45","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13044-016-0034-x","volume":"9","author":"S Razvi","year":"2016","unstructured":"Razvi S, Ingoe L, Ryan V, Pearce SHS, Wilkes S. Study of optimal replacement of Thyroxine in the Elderly (SORTED) - results from the feasibility randomised controlled trial. Thyroid Res. 2016;9:5.","journal-title":"Thyroid Res"},{"issue":"8","key":"186_CR46","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1093\/aje\/kwv254","volume":"183","author":"MA Hern\u00e1n","year":"2016","unstructured":"Hern\u00e1n MA, Robins JM. Using Big Data to emulate a target Trial when a Randomized Trial is not available. Am J Epidemiol. 2016;183(8):758\u201364.","journal-title":"Am J Epidemiol"},{"issue":"1","key":"186_CR47","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s12874-017-0442-1","volume":"17","author":"JC Jakobsen","year":"2017","unstructured":"Jakobsen JC, Gluud C, Wetterslev J, Winkel P. When and how should multiple imputation be used for handling missing data in randomised clinical trials \u2013 a practical guide with flowcharts. BMC Med Res Methodol. 2017;17(1):162.","journal-title":"BMC Med Res Methodol"},{"key":"186_CR48","doi-asserted-by":"publisher","first-page":"b5087","DOI":"10.1136\/bmj.b5087","volume":"340","author":"LE L\u00e9vesque","year":"2010","unstructured":"L\u00e9vesque LE, Hanley JA, Kezouh A, Suissa S. Problem of immortal time bias in cohort studies: example using statins for preventing progression of Diabetes. BMJ. 2010;340:b5087.","journal-title":"BMJ"},{"key":"186_CR49","unstructured":"Hernan MA, Robins JM. Causal Inference: What If."}],"container-title":["Thyroid Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13044-023-00186-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13044-023-00186-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13044-023-00186-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,13]],"date-time":"2023-11-13T01:03:42Z","timestamp":1699837422000},"score":1,"resource":{"primary":{"URL":"https:\/\/thyroidresearchjournal.biomedcentral.com\/articles\/10.1186\/s13044-023-00186-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,13]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["186"],"URL":"https:\/\/doi.org\/10.1186\/s13044-023-00186-0","relation":{},"ISSN":["1756-6614"],"issn-type":[{"value":"1756-6614","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,13]]},"assertion":[{"value":"17 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The University of Sunderland Research Ethics Group has approved this study (application ID 011081). THIN scientific review committee has approved this study, protocol number 22\u2009\u2212\u2009003.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"43"}}